Gene · 580
Papers4,139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,139
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Docking and Molecular Dynamics Simulation Revealed the Potential Inhibitory Activity of Amygdalin in Triple-Negative Breast Cancer Therapeutics Targeting the BRCT Domain of BARD1 Receptor. | Mol Biotechnol | 2024 | 36732462 | PubTator, text mining | PubMed |
| [Precision Medicine for Gastric Cancer: Applicability from the Perspective of Helicobacter pylori Infection]. | Korean J Helicobacter Up Gastrointest Res | 2023 | 40502665 | PubTator, text mining | PubMed |
| Identification of the SIRT1 gene's most harmful non-synonymous SNPs and their effects on functional and structural features-an in silico analysis. | F1000Res | 2023 | 38283900 | PubTator, text mining | PubMed |
| Machine learning in onco-pharmacogenomics: a path to precision medicine with many challenges. | Front Pharmacol | 2023 | 38264526 | PubTator, text mining | PubMed |
| Case report: A safeguard in the sea of variants of uncertain significance: a case study on child with high risk neuroblastoma and acute myeloid leukemia. | Front Oncol | 2023 | 38260858 | PubTator, text mining | PubMed |
| BRCA Mutations and Fertility Preservation. | Int J Mol Sci | 2023 | 38203374 | PubTator, text mining | PubMed |
| Synthetic Lethality by Co-Inhibition of Androgen Receptor and Polyadenosine Diphosphate-Ribose in Metastatic Prostate Cancer. | Int J Mol Sci | 2023 | 38203248 | PubTator, text mining | PubMed |
| Novel Pathogenic Variants in Hereditary Cancer Syndromes in a Highly Heterogeneous Cohort of Patients: Insights from Multigene Analysis. | Cancers (Basel) | 2023 | 38201513 | PubTator, text mining | PubMed |
| Exploiting the DNA Damage Response for Prostate Cancer Therapy. | Cancers (Basel) | 2023 | 38201511 | PubTator, text mining | PubMed |
| The Role of Cancer Stem Cell Markers in Ovarian Cancer. | Cancers (Basel) | 2023 | 38201468 | PubTator, text mining | PubMed |
| Digging into the NGS Information from a Large-Scale South European Population with Metastatic/Unresectable Pancreatic Ductal Adenocarcinoma: A Real-World Genomic Depiction. | Cancers (Basel) | 2023 | 38201431 | PubTator, text mining | PubMed |
| Targeting the Ubiquitin-Proteasome System and Recent Advances in Cancer Therapy. | Cells | 2023 | 38201233 | PubTator, text mining | PubMed |
| PD-L1+ diffuse large B-cell lymphoma with extremely high mutational burden and microsatellite instability due to acquired PMS2 mutation. | Cold Spring Harb Mol Case Stud | 2023 | 38199780 | PubTator, text mining | PubMed |
| Genetic contribution of breast cancer genes in women of black African origin. | Front Genet | 2023 | 38192440 | PubTator, text mining | PubMed |
| Genetic Testing for Successful Cancer Treatment. | Cureus | 2023 | 38179395 | PubTator, text mining | PubMed |
| Molecular and clinical aspects relevant for counseling individuals with clonal hematopoiesis of indeterminate potential. | Front Oncol | 2023 | 38162500 | PubTator, text mining | PubMed |
| Checkpoint Kinase 2 (CHEK2) Gene Mutation in a Patient With Breast and Prostate Cancer: A Unique Presentation of a Rare Disease. | Cureus | 2023 | 38161833 | PubTator, text mining | PubMed |
| A review of genetic variant databases and machine learning tools for predicting the pathogenicity of breast cancer. | Brief Bioinform | 2023 | 38149678 | PubTator, text mining | PubMed |
| The emergence of Fanconi anaemia type S: a phenotypic spectrum of biallelic BRCA1 mutations. | Front Oncol | 2023 | 38146508 | PubTator, text mining | PubMed |
| Prevalence of Variants of Uncertain Significance in Patients Undergoing Genetic Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome. | Cancers (Basel) | 2023 | 38136308 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/580/papers?page=15